Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy.
Mol Ther Oncolytics. 2023 Aug 5;30:117-131. doi: 10.1016/j.omto.2023.08.001. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37654972
Free PMC article.
Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma.
Krabbe T, Marek J, Groll T, Steiger K, Schmid RM, Krackhardt AM, Altomonte J.
Krabbe T, et al. Among authors: marek j.
Cancers (Basel). 2021 Mar 2;13(5):1044. doi: 10.3390/cancers13051044.
Cancers (Basel). 2021.
PMID: 33801359
Free PMC article.
Item in Clipboard
Cite
Cite